BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 38308498)

  • 1. Beyond blood: Advancing the frontiers of liquid biopsy in oncology and personalized medicine.
    Bao Y; Zhang D; Guo H; Ma W
    Cancer Sci; 2024 Apr; 115(4):1060-1072. PubMed ID: 38308498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid biopsy for brain tumors.
    Shankar GM; Balaj L; Stott SL; Nahed B; Carter BS
    Expert Rev Mol Diagn; 2017 Oct; 17(10):943-947. PubMed ID: 28875730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid biopsy for cancer management: a revolutionary but still limited new tool for precision medicine.
    Arechederra M; Ávila MA; Berasain C
    Adv Lab Med; 2020 Oct; 1(3):20200009. PubMed ID: 37361495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid Biopsies as Non-Invasive Tools for Mutation Profiling in Multiple Myeloma: Application Potential, Challenges, and Opportunities.
    Heestermans R; Schots R; De Becker A; Van Riet I
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer and liquid biopsies: Clinical applications and challenges.
    Urabe F; Sumiyoshi T; Tashiro K; Goto T; Kimura T; Kobayashi T
    Int J Urol; 2024 Jun; 31(6):617-626. PubMed ID: 38551314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Profiling of Liquid Biopsy Samples for Precision Medicine.
    Campos CDM; Jackson JM; Witek MA; Soper SA
    Cancer J; 2018; 24(2):93-103. PubMed ID: 29601336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing Liquid Biopsies in Clinical Trials: State of Affairs, Opportunities, and Challenges.
    Lustberg MB; Stover DG; Chalmers JJ
    Cancer J; 2018; 24(2):61-64. PubMed ID: 29601331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas.
    Valerius AR; Webb MJ; Hammad N; Sener U; Malani R
    Curr Oncol Rep; 2024 Apr; 26(4):377-390. PubMed ID: 38488990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid biopsy: current technology and clinical applications.
    Nikanjam M; Kato S; Kurzrock R
    J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid Biopsy as Novel Tool in Precision Medicine: Origins, Properties, Identification and Clinical Perspective of Cancer's Biomarkers.
    Fernández-Lázaro D; García Hernández JL; García AC; Córdova Martínez A; Mielgo-Ayuso J; Cruz-Hernández JJ
    Diagnostics (Basel); 2020 Apr; 10(4):. PubMed ID: 32294884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of new techniques and clinical applications of liquid biopsy in lung cancer management.
    Chen K; He Y; Wang W; Yuan X; Carbone DP; Yang F
    Sci Bull (Beijing); 2024 May; 69(10):1556-1568. PubMed ID: 38641511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Utility of Liquid Biopsy as a Diagnostic and Prognostic Tool for the Assessment of Solid Tumors: Implications in the Precision Oncology.
    Mathai RA; Vidya RVS; Reddy BS; Thomas L; Udupa K; Kolesar J; Rao M
    J Clin Med; 2019 Mar; 8(3):. PubMed ID: 30889786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancements and Applications of Liquid Biopsies in Oncology: A Narrative Review.
    Noor J; Chaudhry A; Noor R; Batool S
    Cureus; 2023 Jul; 15(7):e42731. PubMed ID: 37654932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and future applications of liquid biopsy in non-small-cell lung cancer-a narrative review.
    Tomasik B; Skrzypski M; Bieńkowski M; Dziadziuszko R; Jassem J
    Transl Lung Cancer Res; 2023 Mar; 12(3):594-614. PubMed ID: 37057121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced liquid biopsy technologies for circulating biomarker detection.
    Soda N; Rehm BHA; Sonar P; Nguyen NT; Shiddiky MJA
    J Mater Chem B; 2019 Nov; 7(43):6670-6704. PubMed ID: 31646316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology.
    Muinelo-Romay L; Casas-Arozamena C; Abal M
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30087246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell free circulating tumor nucleic acids, a revolution in personalized cancer medicine.
    Kerachian MA; Poudineh A; Thiery JP
    Crit Rev Oncol Hematol; 2019 Dec; 144():102827. PubMed ID: 31715326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer diagnosis: from tumor to liquid biopsy and beyond.
    Vaidyanathan R; Soon RH; Zhang P; Jiang K; Lim CT
    Lab Chip; 2018 Dec; 19(1):11-34. PubMed ID: 30480287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine biopsy technologies: Cancer and beyond.
    Chen CK; Liao J; Li MS; Khoo BL
    Theranostics; 2020; 10(17):7872-7888. PubMed ID: 32685026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering State-of-the-Art Plasmonic Nanomaterials for SERS-Based Clinical Liquid Biopsy Applications.
    Wang J; Koo KM; Wang Y; Trau M
    Adv Sci (Weinh); 2019 Dec; 6(23):1900730. PubMed ID: 31832306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.